Back to Screener

Healthcare

BioDelivery Sciences International, Inc.(BDSI)

Live Price

Offline

$5.59

-0.09% today

1Y Change

—

Window

No data

Market Cap
$577.05M
Revenue Growth
+6.5%
EPS Growth
+215.4%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

BioDelivery Sciences International, Inc. (BDSI) is a Healthcare stock with a market cap of $577.05M. The stock last traded around $5.59. Baseline metrics include revenue growth of +6.5%, EPS growth of +215.4%, a dividend yield of 0.0%. What stands out right now is revenue +6.5%, EPS +215.4%, free cash flow +62.7% with operating margin 22.3% and ROIC 15.0%. Valuation is more restrained than many high-expectation growth names at P/E 6.8 and price/sales 3.5. Stock Foundry combines BDSI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Near sector median

+6.5% vs +7.6% peer median

Operating Margin

Above sector median

+22.3% vs +19.4% peer median

P/E

Below sector median

6.8 vs 36.3 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report landed above expectations

2022 was reported on Mar 9, 2022 with an EPS surprise of +2483.3% and a revenue surprise of -10.7%.

The operating story is still moving forward

Revenue is running at +6.5% and EPS at +215.4%, with operating margin around 22.3%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

BDSI

—

Normalized return

SPY

—

S&P 500

Excess Return

—

Relative to SPY

BDSI Max Drawdown

—

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BDSI and SPY.

Calendar-year return history is still loading or unavailable.
BI

Company Overview

BioDelivery Sciences International, Inc.

Last Updated
May 7, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
6.8
EV/EBITDA
11.7
Price/Sales
3.5
Price/Book
3.1

Growth

Revenue
+6.5%
EPS
+215.4%
Free Cash Flow
+62.7%

Profitability

Gross Margin
86.0%
Operating Margin
22.3%
Net Margin
50.9%
ROE
57.3%
ROIC
15.0%

Balance Sheet

Debt/Equity
0.31
Current Ratio
2.45

Earnings Reports

📅 Last reportedMar 9, 2022
PeriodB/MEPSEPS ΔRevenueRev Δ
—
Mar 9, 22
✓
0.62
Est 0.02
+2483.3%
43154.0B
Est 48340.0B
-10.7%
—
Nov 3, 21
✓
0.07
Est 0.06
+16.7%
41092.0B
Est 44070.0B
-6.8%
—
Aug 4, 21
✓
0.09
Est 0.05
+80.0%
41439.0B
Est 30768.5B
+34.7%
—
May 6, 21
✗
0.05
Est 0.07
-28.6%
41020.0B
Est 38720.0B
+5.9%
—
Mar 10, 21
✓
0.10
Est 0.06
+66.7%
42167.0B
Est —
—
—
Nov 5, 20
✓
0.09
Est 0.06
+50.0%
39443.0B
Est 26295.3B
+50.0%
—
Aug 5, 20
✗
0.01
Est 0.04
-73.9%
36582.0B
Est 146328.0B
-75.0%
—
May 7, 20
✓
0.05
Est 0.02
+207.7%
38278.0B
Est 15311.2B
+150.0%
—
Mar 12, 20
✓
0.04
Est 0.01
+300.0%
111389.0B
Est 31637.0B
+252.1%
—
Nov 12, 19
✓
0.00
Est 0.00
+100.6%
30306.0B
Est 59936.3B
-49.4%
—
Aug 8, 19
✗
-0.13
Est -0.06
-121.3%
29677.0B
Est 27544.0B
+7.7%
—
May 6, 19
✓
-0.05
Est -0.08
+37.5%
19769.0B
Est 31630.4B
-37.5%
—
Mar 14, 19
✓
-0.08
Est -0.10
+20.0%
18029.0B
Est 22536.3B
-20.0%
—
Nov 8, 18
✓
-0.10
Est -0.13
+23.1%
14156.0B
Est 12127.9B
+16.7%
—
Aug 9, 18
✓
-0.16
Est -0.18
+11.1%
12175.0B
Est 13696.9B
-11.1%
—
May 10, 18
✓
-0.18
Est -0.21
+14.3%
11281.0B
Est 13161.2B
-14.3%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks